senate Bill S6044

Signed By Governor
2021-2022 Legislative Session

Establishes an online directory for distributors of opioid antagonists

download bill text pdf

Sponsored By

Current Bill Status - Signed by Governor


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (13)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Oct 07, 2021 signed chap.434
Oct 06, 2021 delivered to governor
Jun 07, 2021 returned to senate
passed assembly
ordered to third reading rules cal.405
substituted for a128
May 19, 2021 referred to alcoholism and drug abuse
delivered to assembly
passed senate
May 12, 2021 advanced to third reading
May 11, 2021 2nd report cal.
May 10, 2021 1st report cal.937
Mar 31, 2021 referred to alcoholism and substance abuse

Votes

view votes

May 10, 2021 - Alcoholism and Substance Abuse committee Vote

S6044
7
0
committee
7
Aye
0
Nay
0
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Alcoholism and Substance Abuse committee vote details

Alcoholism and Substance Abuse Committee Vote: May 10, 2021

Co-Sponsors

S6044 (ACTIVE) - Details

See Assembly Version of this Bill:
A128
Law Section:
Mental Hygiene Law
Laws Affected:
Amd §19.09, Ment Hyg L
Versions Introduced in Other Legislative Sessions:
2017-2018: A10991
2019-2020: S4499, A307

S6044 (ACTIVE) - Summary

Directs the office of addiction services and supports to maintain an online directory of distributors of opioid antagonists.

S6044 (ACTIVE) - Sponsor Memo

S6044 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   6044
 
                        2021-2022 Regular Sessions
 
                             I N  S E N A T E
 
                              March 31, 2021
                                ___________
 
 Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
   printed to be committed to the Committee on Alcoholism  and  Substance
   Abuse
 
 AN  ACT  to  amend  the mental hygiene law, in relation to requiring the
   office of addiction services and supports to maintain an online direc-
   tory of distributors of opioid antagonists

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Section  19.09  of  the  mental hygiene law is amended by
 adding a new subdivision (l) to read as follows:
   (L)(1) THE OFFICE, IN CONSULTATION  WITH  THE  DEPARTMENT  OF  HEALTH,
 SHALL  MAINTAIN  ON  ITS  WEBSITE  A PUBLICLY AVAILABLE DIRECTORY OF ALL
 DISTRIBUTORS OF OPIOID ANTAGONISTS TO  THE  PUBLIC,  INCLUDING  BUT  NOT
 LIMITED TO, PHARMACIES, PREVENTION PROGRAMS AND NOT-FOR-PROFITS. AS USED
 IN  THIS SUBDIVISION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEAN-
 INGS:
   (I) "OPIOID" MEANS  AN  OPIATE  AS  DEFINED  IN  SECTION  THIRTY-THREE
 HUNDRED TWO OF THE PUBLIC HEALTH LAW.
   (II)  "OPIOID  ANTAGONIST"  MEANS  A FEDERAL FOOD AND DRUG ADMINISTRA-
 TION-APPROVED DRUG THAT, WHEN ADMINISTERED, NEGATES  OR  NEUTRALIZES  IN
 WHOLE  OR  IN PART THE PHARMACOLOGICAL EFFECTS OF AN OPIOID IN THE BODY.
 THE OPIOID ANTAGONIST SHALL BE LIMITED TO NALOXONE OR OTHER  MEDICATIONS
 APPROVED BY THE DEPARTMENT OF HEALTH FOR THIS PURPOSE.
   (2)  THE  DIRECTORY  REQUIRED BY THIS SUBDIVISION SHALL INCLUDE AND BE
 SEARCHABLE BY THE FOLLOWING INFORMATION:
   (I) ADDRESSES OF EACH DISTRIBUTOR OF OPIOID ANTAGONISTS;
   (II) CONTACT INFORMATION, SUCH AS PHONE NUMBERS  OR  EMAIL  ADDRESSES,
 FOR EACH DISTRIBUTOR;
   (III)  SERVICES  OFFERED  BY EACH DISTRIBUTOR AT EACH LOCATION IF MORE
 THAN ONE, AS WELL AS INFORMATION PROVIDING WHICH OPIOID ANTAGONISTS  ARE
 CURRENTLY AVAILABLE AT EACH DISTRIBUTOR;
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.